May 22, 2013, 2:13 am
Most Recent
Most Read
Filed under: Investing Alnylam to Webcast Presentation at Deutsche Bank 38 th Annual dbAccess Health Care Conference CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (NAS: ALNY) , a leading RNAi therapeutics...
16.9 hours on dailyfinance.com
SAN FRANCISCO (Reuters) - Yahoo Inc Chief Executive Marissa Mayer's $1.1 billion acquisition of blogging service Tumblr will be a test of her ability to revive the aging Web portal. Luckily for her, her performance may be graded generously. Mayer...
17.2 hours on businessinsider.com
Here's a healthy reminder that the issues that outrage and fascinate members of the media are often quite different than the ones that media consumers (a.k.a., normal people) care about. According to a new Pew survey, of the three scandals plaguing...
20.5 hours on businessinsider.com
Filed under: Investing AmSurg Corp. to Present at the Deutsche Bank 38 th Annual dbAccess Health Care Conference NASHVILLE, Tenn.--(BUSINESS WIRE)-- AmSurg Corp. (NAS: AMSG) today announced that it will...
20.6 hours on dailyfinance.com
Filed under: Investing St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYS: STJ) will present at the 38th Annual Deutsche...
24.6 hours on dailyfinance.com
If a client is considering a later-in-life marriage, understand that prenuptial agreements can’t ‘hide’ assets when it comes to a spouse’s need for...
25.4 hours on advisorone.com
Last week, representatives of many of the world’s leading cities – including London, Boston, Mexico City, Barcelona and Christchurch – came to San Francisco to learn from Silicon Valley entrepreneurs about how to make their...
39.4 hours on techcrunch.com
Filed under: Investing Invacare Corporation to Present at Deutsche Bank Securities, Inc. 38th Annual Health Care Conference ELYRIA, Ohio--(BUSINESS WIRE)-- Robert K. Gudbranson, Senior Vice President and Chief...
39.9 hours on dailyfinance.com
Filed under: Investing Biotech company Peregrine Pharmaceuticals was up as much as 33% today after announcing that it's starting a phase 3 trial for bavituximab in non-small-cell lung cancer. You read that right. Not up 33% because its...
41.1 hours on dailyfinance.com
“The governor has a notion that you can move away from medical billing and towards a more flexible approach to health-care spending that makes more sense for the community,” John McConnell, a health economist at Oregon Health and Science...
43.9 hours on washingtonpost.com